Abstract:Gamma Knife radiosurgery (GKRS) is a well-established technique in radiation therapy (RT) for treating small-size brain tumors. It administers highly concentrated doses during each treatment fraction, with even minor dose errors posing a significant risk of causing severe damage to healthy tissues. It underscores the critical need for precise and meticulous precision in GKRS. However, the planning process for GKRS is complex and time-consuming, heavily reliant on the expertise of medical physicists. Incorporating deep learning approaches for GKRS dose prediction can reduce this dependency, improve planning efficiency and homogeneity, streamline clinical workflows, and reduce patient lagging times. Despite this, precise Gamma Knife plan dose distribution prediction using existing models remains a significant challenge. The complexity stems from the intricate nature of dose distributions, subtle contrasts in CT scans, and the interdependence of dosimetric metrics. To overcome these challenges, we have developed a "Cascaded-Deep-Supervised" Convolutional Neural Network (CDS-CNN) that employs a hybrid-weighted optimization scheme. Our innovative method incorporates multi-level deep supervision and a strategic sequential multi-network training approach. It enables the extraction of intra-slice and inter-slice features, leading to more realistic dose predictions with additional contextual information. CDS-CNN was trained and evaluated using data from 105 brain cancer patients who underwent GKRS treatment, with 85 cases used for training and 20 for testing. Quantitative assessments and statistical analyses demonstrated high consistency between the predicted dose distributions and the reference doses from the treatment planning system (TPS). The 3D overall gamma passing rates (GPRs) reached 97.15% ± 1.36% (3 mm/3%, 10% threshold), surpassing the previous best performance by 2.53% using the 3D Dense U-Net model. When evaluated against more stringent criteria (2 mm/3%, 10% threshold, and 1 mm/3%, 10% threshold), the overall GPRs still achieved 96.53% ± 1.08% and 95.03% ± 1.18%. Furthermore, the average target coverage (TC) was 98.33% ± 1.16%, dose selectivity (DS) was 0.57 ± 0.10, gradient index (GI) was 2.69 ± 0.30, and homogeneity index (HI) was 1.79 ± 0.09. Compared to the 3D Dense U-Net, CDS-CNN predictions demonstrated a 3.5% improvement in TC, and CDS-CNN's dose prediction yielded better outcomes than the 3D Dense U-Net across all evaluation criteria. The experimental results demonstrated that the proposed CDS-CNN model outperformed other models in predicting GKRS dose distributions, with predictions closely matching the TPS doses.

Radiotherapy Sensitivity Prediction For Glioma Based On Graph Convolutional Networks.

Lymph Node Gross Tumor Volume Detection in Oncology Imaging via Relationship Learning Using Graph Neural Network

Radiotherapy Target Contouring with Convolutional Gated Graph Neural Network

Prediction and interpretation of cancer survival using graph convolution neural networks

A Machine Learning‐based Survival Prediction Model of High Grade Glioma by Integration of Clinical and Dose‐volume Histogram Parameters

Predicting isocitrate dehydrogenase mutation status in glioma using structural brain networks and graph neural networks

An Automated Approach for Predicting Glioma Grade and Survival of LGG Patients Using CNN and Radiomics.

Enhanced 3D dose prediction for hypofractionated SRS (gamma knife radiosurgery) in brain tumor using cascaded-deep-supervised convolutional neural network

PathoGraph: An Attention-Based Graph Neural Network Capable of Prognostication Based on CD276 Labelling of Malignant Glioma Cells

Immunotherapy Efficacy Prediction for Non-small Cell Lung Cancer Using Multi-view Adaptive Weighted Graph Convolutional Networks

Enhanced brain tumor classification using graph convolutional neural network architecture

Nimg-74. A Novel Approach For Personalized Radiotherapy Target Volume Definition Using Metabolic Mri And Deep Learning-Driven Predictions Of Glioblastoma Recurrence

Transfer Learning-Based Autosegmentation of Primary Tumor Volumes of Glioblastomas Using Preoperative MRI for Radiotherapy Treatment

TransDose: Transformer-based Radiotherapy Dose Prediction from CT Images guided by Super-Pixel-Level GCN Classification

Deep learning for the prediction of residual tumor after radiotherapy and treatment decision-making in patients with nasopharyngeal carcinoma based on magnetic resonance imaging

Using deep learning models to analyze the cerebral edema complication caused by radiotherapy in patients with intracranial tumor

Overall Survival Time Prediction of Glioblastoma on Preoperative MRI Using Lesion Network Mapping

Brain Tumor Segmentation Using an Ensemble of 3D U-Nets and Overall Survival Prediction Using Radiomic Features

Survival Prediction Across Diverse Cancer Types Using Neural Networks

Multi-Channel 3D Deep Feature Learning for Survival Time Prediction of Brain Tumor Patients Using Multi-Modal Neuroimages

Post-Radiotherapy PET Image Outcome Prediction by Deep Learning Under Biological Model Guidance: A Feasibility Study of Oropharyngeal Cancer Application